Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-022471
Filing Date
2018-07-23
Accepted
2018-07-23 11:33:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31996
  Complete submission text file 0000000000-18-022471.txt   44837
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filed for) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)